RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Asahi Kasei Pharma
A

Asahi Kasei Pharma portfolio

Asahi Kasei Pharma has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $168M.
Latest deal: Mediar Therapeutics · Jan 7, 2026.
About this page

Its most recent investment on record is Mediar Therapeutics's $76M Series B+ round in January 2026, alongside Longwood Fund, Amplitude Venture Capital, Intermediate Capital Group and 1 other. By category, its portfolio leans toward Health and bio (2). It has co-invested with Longwood Fund, Intermediate Capital Group and Amplitude Venture Capital, most often Longwood Fund (2 rounds).

What Asahi Kasei Pharma invests in

How Asahi Kasei Pharma invests

StageDealsCapital in rounds
Series B+ 2 100%$168M
YearDealsCapital in rounds
2021 1 50%$92M
2026 1 50%$76M

Asahi Kasei Pharma portfolio companies

CompanyRound with Asahi Kasei PharmaTotal raisedLatest raise
MMediar Therapeutics
Health and bio
 Series B+ · $76M$181MJan 7, 2026
Series B+
PPulmocide
Health and bio
 Series B+ · $92M$174.4MDec 6, 2022
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Asahi Kasei Pharma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Asahi Kasei Pharma, which is a subset of its real portfolio. API: /api/v1/investors/asahi-kasei-pharma (get a free API key). More: the most active VC firms and new venture capital funds.